iNOS upregulation and nitrotyrosine immunoreactivity have been demonstrated in conditions such as endotoxemia, IBD, Helicobacter pylori gastritis, as well as in animal models of colitis and ileitis, suggesting that peroxynitrite may be a key mediator of mucosal injury and gut barrier failure [39]. Here, NOS2 is linked to inflammatory bowel disease.